Published on in Vol 25 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/42310, first published .
Development of a Virtual Human for Supporting Tobacco Cessation During the COVID-19 Pandemic

Development of a Virtual Human for Supporting Tobacco Cessation During the COVID-19 Pandemic

Development of a Virtual Human for Supporting Tobacco Cessation During the COVID-19 Pandemic

Journals

  1. Arnold V, Purnat T, Marten R, Pattison A, Gouda H. Chatbots and COVID-19: Taking Stock of the Lessons Learned. Journal of Medical Internet Research 2024;26:e54840 View
  2. Lee S, Yoon J, Cho Y, Chun J. A systematic review of chatbot-assisted interventions for substance use. Frontiers in Psychiatry 2024;15 View
  3. Olawade D, Aienobe-Asekharen C. Artificial intelligence in tobacco control: A systematic scoping review of applications, challenges, and ethical implications. International Journal of Medical Informatics 2025;202:105987 View
  4. Kalan E, Dadipoor S, Osibogun O, Ben Taleb Z. The Roles of AI in Tobacco and Nicotine Research and Regulation. Substance Use & Misuse 2025:1 View
  5. Harding N, Bovopoulos N, Caspi D, Martin C, McPhie S, Bouadjenek M, Aryal S, Hobbs M. A Scoping Review of Large Language Model Chatbot Use for Alcohol and Other Drug Health Information. Drug and Alcohol Review 2025 View
  6. Tang C, Wang L, Pan D, Zhang H, Fang Y. Matching embodied conversational agent appearance to message emotion enhances persuasion in eHealth. Scientific Reports 2025;15(1) View